THE TUMOR-INHIBITING EFFECT OF DIETHYLSTILBESTROL AND ITS DIPHOSPHATE ON THE NB-H AND NB-R PROSTATIC CARCINOMAS OF THE RAT

被引:12
作者
SCHNEIDER, MR
HUMM, A
GRAF, AH
机构
[1] UNIV REGENSBURG,INST PHARM,W-8400 REGENSBURG,GERMANY
[2] UNIV INNSBRUCK,INST PATHOL ANAT,A-6020 INNSBRUCK,AUSTRIA
关键词
Accessory sex organs; Diethylstilbestrol; Honvan; Morphometry; Noble Nb prostate tumors;
D O I
10.1007/BF01612671
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
For many years, diethylstilbestrol (DES) and its diphosphate (DES PP; Honvan) have been standard therapies for prostatic carcinoma. The effects of DES, its monophosphate (DES P) and of DES PP on the weights of accessory sex organs of mice and rats, and on the experimental Noble Nb-H and Nb-R prostatic carcinomas of the rat were, therefore, compared. In intact mature mice, all three compounds led to a strong and dose-dependent inhibition of seminal vesicle weights and testosterone levels, whereas only a slight antiandrogenic activity in castrated mice was found. In intact rats, DES, DES P and DESPP strongly inhibited accessory sex organ weights and testosterone levels. In castrated rats, however, no antiandrogenic activity was determinable. The prostate carcinoma-inhibiting effects of DES and DESPP were tested in comparison with castration in the transplantable hormone-sensitive Nb-H and Nb-R prostatic carcinoma in rats. Whereas castration caused only a retardation of tumor growth, DES and DES PP (3×0.1 mg/kg and 1.0 mg/kg weekly s.c.) led to an almost complete inhibition, which was significantly (P<0.01) better than the effect of castration. As the weights of accessory sex organs were identically reduced by either castration or the estrogens, a direct tumor-inhibiting effect of DES and DES PP in addition to their testosterone-lowering activity is obvious. This was proved in an experiment with castrated rats. The only slightly inhibitory activity of castration was strongly potentiated by concomitant administration of DES. Moreover, histological examinations revealed that Nb-H and Nb-R tumors were much more damaged by treatment with DES or DES PP than after castration. Morphometry of the tumors showed that tumor reduction is associated with a decrease in the ratio of the epithelial to the stromal density, i.e. there was an even more pronounced decrease in epithelial cells than that found by merely measuring tumor area. These studies show that the prostate carcinoma-inhibiting effect of DES and DES PP in the Nb model is superior to the effect of castration and that they act directly on the tumor cells used, even in castrated rats. © 1990 Springer-Verlag.
引用
收藏
页码:159 / 167
页数:9
相关论文
共 19 条
[1]  
BRANDES LJ, 1983, CANCER RES, V43, P2831
[2]  
DAEHLIN L, 1987, UROL RES, V15, P169
[3]  
Drago J R, 1980, Prog Clin Biol Res, V37, P325
[4]  
Drago J R, 1980, Prog Clin Biol Res, V37, P265
[5]  
GELLER J, 1983, SEMIN ONCOL, V10, P34
[6]  
GRIFFITHS K, 1981, HORMONAL MANAGEMENT, P131
[7]  
IP MM, 1980, CANCER RES, V40, P2188
[8]  
KADOHAMA N, 1985, J NATL CANCER I, V74, P475
[9]   ANTIESTROGENS DO NOT COUNTERACT THE INHIBITORY EFFECT OF ESTRADIOL-17-BETA ON THE GROWTH OF THE DUNNING R3327 PROSTATIC ADENOCARCINOMA [J].
LANDSTROM, M ;
DAMBER, JE ;
BERGH, A ;
TOMIC, R ;
CARLSSONBOSTEDT, L ;
STIGBRAND, T .
PROSTATE, 1988, 12 (04) :287-298
[10]  
OELSCHLAGER H, 1984, ARZNEIMITTELFORSCH, V34-2, P1333